Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Decitabine and Vaccine Therapy for Pediatric Brain Tumors
NCT02332889Phase 2Terminated
- Sponsor
- University of Louisville
- Start
- Apr 2015
- Primary completion
- Jul 2016
- Modality
- Prophylactic Vaccines, Whole Cell Cancer Vaccines, Dendritic Cell Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of autologous dendritic cell vaccine in high-grade glioma (HGG), medulloblastoma, Central Nervous System Primitive Neuroectodermal Tumor, sponsored by University of Louisville. Started Apr 2015; status: terminated.
02
Drugs
autologous dendritic cell vaccine
03
Conditions
high-grade glioma (HGG)medulloblastomaCentral Nervous System Primitive Neuroectodermal Tumor
Beyond the preview
Go deeper on NCT02332889.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02332889.